acrux update /bioshares, page-5

  1. 1,546 Posts.
    lightbulb Created with Sketch. 5
    A deal in the next month and a half would be good. Otherwise I might start getting worried.

    I'll be happy with any deal that provides enough up front for them to avoid any more capital raisings and keep the rest of the product pipeline moving, but I think there's a chance it could be a quite significant sum. KV (over)paid Vivus US$150 million for Evamist, but that kind of sum actually seems reasonable for Axiron.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $6.524M
Open High Low Value Volume
1.5¢ 1.6¢ 1.5¢ $9.887K 624.5K

Buyers (Bids)

No. Vol. Price($)
1 6355 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 20000 1
View Market Depth
Last trade - 15.00pm 26/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.